{"contraindications":{"vaccineGroup":{"contraindication":[{"observationCode":"080","observationTitle":"Adverse reaction to vaccine component","contraindicationText":"Do not vaccinate if the patient has had an adverse reaction to a vaccine component."},{"observationCode":"082","observationTitle":"Severe allergic reaction after previous dose of Japanese Encephalitis","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Japanese Encephalitis vaccine."},{"observationCode":"115","observationTitle":"Severe allergic reaction to protamine sulfate","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to protamine sulfate."}]}},"series":[{"seriesName":"Japanese Encephalitis risk 2-dose series","targetDisease":"Japanese Encephalitis","vaccineGroup":"Japanese Encephalitis","seriesAdminGuidance":["For adults and children, a booster dose (i.e., third dose) should be given on or after 1 year after completion of the primary JE-VC series if ongoing exposure or reexposure to JE virus is expected"]},{"seriesName":"Japanese Encephalitis risk 2-dose series 18-64 years","targetDisease":"Japanese Encephalitis","vaccineGroup":"Japanese Encephalitis","seriesAdminGuidance":["For adults and children, a booster dose (i.e., third dose) should be given on or after 1 year after completion of the primary JE-VC series if ongoing exposure or reexposure to JE virus is expected"]}]}